Skip to main content

Funded Grants

Filter by:
Clear Filters
Filter by:
Gabriella Gobbi , McGill University × Clear Filters

1 results found

Novel First-In-Class Melatonin MT2 Receptor Agonist for Neuropathic Pain: Investigational New Drug (IND) – Enabling Studies

Neuropathic pain is a chronic pain disorder resulting from damage to the nerves.


Grant type
Team grants
Area of Research
Central Nervous System
Competition
CQDM - Brain Canada - SynergiQc
Province
Québec
Start Date
2019